Evaluation and Management of the Infant Exposed to HIV-1 in the United States

被引:25
作者
Havens, Peter L.
Mofenson, Lynne M.
机构
关键词
human immunodeficiency virus; HIV-1; perinatal transmission; antiretroviral prophylaxis; diagnosis; infant; TO-CHILD TRANSMISSION; IMMUNODEFICIENCY-VIRUS TYPE-1; POLYMERASE CHAIN-REACTION; SINGLE-DOSE NEVIRAPINE; PERSISTENT MITOCHONDRIAL DYSFUNCTION; PNEUMOCYSTIS-CARINII PNEUMONIA; 1-INFECTED PREGNANT-WOMEN; PERINATAL TRANSMISSION; ANTIRETROVIRAL THERAPY; UNINFECTED INFANTS;
D O I
10.1542/peds.2008-3076
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The pediatrician plays a key role in the prevention of mother-to-child transmission of HIV-1 infection. For infants born to women with HIV-1 infection identified during pregnancy, the pediatrician ensures that antiretroviral prophylaxis is provided to the infant to decrease the risk of acquiring HIV-1 infection and promotes avoidance of postnatal HIV-1 transmission by advising HIV-1-infected women not to breastfeed. The pediatrician should perform HIV-1 antibody testing for infants born to women whose HIV-1 infection status was not determined during pregnancy or labor. For HIV-1-exposed infants, the pediatrician monitors the infant for early determination of HIV-1 infection status and for possible short- and long-term toxicity from antiretroviral exposures. Provision of chemoprophylaxis for Pneumocystis jiroveci pneumonia and support of families living with HIV-1 by providing counseling to parents or caregivers are also important components of care. Pediatrics 2009; 123: 175-187
引用
收藏
页码:175 / 187
页数:13
相关论文
共 79 条
[1]   Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy [J].
Alimenti, A ;
Burdge, DR ;
Ogilvie, GS ;
Money, DM ;
Forbes, JC .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (09) :782-788
[2]  
*AM AC PED, 2006, RED BOOK 2006 REP CO, P678
[3]  
American College of Obstetricians and Gynecologists, 2004, OBSTET GYNECOL, V104, P1119
[4]  
[Anonymous], 2007, CLIN INFECT DIS
[5]  
[Anonymous], PUBL HLTH SERV TASK
[6]   Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort [J].
Barret, B ;
Tardieu, M ;
Rustin, P ;
Lacroix, C ;
Chabrol, B ;
Desguerre, I ;
Dollfus, C ;
Mayaux, MJ ;
Blanche, S .
AIDS, 2003, 17 (12) :1769-1785
[7]   Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues [J].
Blanche, S ;
Tardieu, M ;
Rustin, P ;
Slama, A ;
Barret, B ;
Firtion, G ;
Ciraru-Vigneron, N ;
Lacroix, C ;
Rouzioux, C ;
Mandelbrot, L ;
Desguerre, I ;
Rötig, A ;
Mayaux, MJ ;
Delfraissy, JF .
LANCET, 1999, 354 (9184) :1084-1089
[8]   Mitochondrial dysfunction following perinatal exposure to nucleoside analogues [J].
Blanche, Stephane ;
Tardieu, Marc ;
Benhammou, Valerie ;
Warszawski, Josiane ;
Rustin, Pierre .
AIDS, 2006, 20 (13) :1685-1690
[9]   Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005 [J].
Bottiger, D ;
Johansson, NG ;
Samuelsson, B ;
Zhang, H ;
Putkonen, P ;
Vrang, L ;
Oberg, B .
AIDS, 1997, 11 (02) :157-162
[10]   PHASE-1 EVALUATION OF ZIDOVUDINE ADMINISTERED TO INFANTS EXPOSED AT BIRTH TO THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
BOUCHER, FD ;
MODLIN, JF ;
WELLER, S ;
RUFF, A ;
MIROCHNICK, M ;
PELTON, S ;
WILFERT, C ;
MCKINNEY, R ;
CRAIN, MJ ;
ELKINS, MM ;
BLUM, MR ;
PROBER, CG .
JOURNAL OF PEDIATRICS, 1993, 122 (01) :137-144